SHOC2 can also promote the expression of LGALS3BP (lectin galactoside-binding soluble 3 binding protein) and so on to control the effect of ERK1/2 pathway on cell movement and adhesion, and the high expression of such proteins in blood and tumor tissues was associated with poor prognosis [36]. The gene discussed is LGALS3BP; the disease is neoplasm.